Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00693420 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash Prominence
A Phase 3 study, sponsored by Allergan.
- Completed
- Registry status
- Phase 3
- Development phase
- 278
- Enrollment target
NCT00693420 is a Phase 3 study that has completed, run by Allergan. The registered enrollment target is 278 participants.
The verdict
NCT00693420, a Phase 3 study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 278 participants
- Enrollment target
Study Summary
This study evaluates the safety and effectiveness of topical bimatoprost solution for enhancing eyelash prominence.
Interventions
- DRUG Bimatoprost 0.03% sterile solution
- DRUG vehicle sterile solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 278 participants |
| Start Date | 2007-04 |
| Est. Completion | 2007-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00693420
The ClinicalTrials.gov registry entry for NCT00693420 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 278 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bimatoprost 0.03% sterile solution is the first listed.
NCT00693420 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00693420 about?
NCT00693420 is a clinical study titled "Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash Prominence". This study evaluates the safety and effectiveness of topical bimatoprost solution for enhancing eyelash prominence.
What is the current status of trial NCT00693420?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 278 participants. The study started on 2007-04. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00693420?
The interventions under investigation include: Bimatoprost 0.03% sterile solution (DRUG), vehicle sterile solution (DRUG).
Who is sponsoring clinical trial NCT00693420?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.